Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014644
Filing Date
2024-11-06
Accepted
2024-11-06 16:27:39
Documents
92
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pahc-20240930x10q.htm   iXBRL 10-Q 1828935
2 EX-31.1 pahc-20240930xex31d1.htm EX-31.1 8162
3 EX-31.2 pahc-20240930xex31d2.htm EX-31.2 8132
4 EX-32.1 pahc-20240930xex32d1.htm EX-32.1 3885
5 EX-32.2 pahc-20240930xex32d2.htm EX-32.2 4155
  Complete submission text file 0001558370-24-014644.txt   8541644

Data Files

Seq Description Document Type Size
6 EX-101.SCH pahc-20240930.xsd EX-101.SCH 60395
7 EX-101.CAL pahc-20240930_cal.xml EX-101.CAL 78300
8 EX-101.DEF pahc-20240930_def.xml EX-101.DEF 304137
9 EX-101.LAB pahc-20240930_lab.xml EX-101.LAB 438649
10 EX-101.PRE pahc-20240930_pre.xml EX-101.PRE 473220
95 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20240930x10q_htm.xml XML 1488642
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 241431468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)